News, Conferences & Events
Explore our news page for a glimpse into our company's activities, featuring articles on conferences and scientific collaborations that drive innovation and industry trends.
Sussex Research Laboratories Inc. is attending the 32nd International Carbohydrate Symposium (ICS 2026)
Sussex Research Laboratories Inc. is attending the 2026 Gordon Research Conference (GRC)
Sussex Research Laboratories Inc. is heading to BIO International Convention in San Diego
Sussex Research Laboratories Inc. x Canada-UK Grant on Enabling Technologies and Innovations for Biomanufacturing of Biologics and Advanced Therapeutics
Sussex Research Laboratories Inc. x Embassy of Canada to Switzerland
Sussex Research and 48Hour Discovery Announce Strategic Partnership to Develop and Commercialize Game-Changing Liquid Glycan Array (LiGA) Reagents Designed to Enable High-Throughput, Multiplex Profiling of Protein–Glycan Interactions on Cell Surfaces
Sussex Research Laboratories Inc. is headed to the Canadian Societies for Chemistry and Chemical Engineering 2026 Conferences and Exhibition
Sussex Research Laboratories Inc. is pleased to announce the promotion of Dr. Ryan P. Sweeney to Associate Director of Carbohydrate Chemistry x Canadian Glycomics Symposium (CGS) 2026
Sussex Research Laboratories Inc. will be attending the Eureka Network Global Innovation Summit in Basel, Switzerland
Sussex Research Laboratories Inc. is ISO 9001:2015 Certified!
Sussex Research Laboratories Inc. is heading to Swiss Biotech Day 2026!
MITACS Accelerate x SRL x uAlberta
Sussex Research Laboratories Inc. to Attend Keystone Symposia on Molecular & Cellular Biology
Sussex Research Laboratories Inc. Receives Support to Advance Oligonucleotide Therapeutics via Glycoscience
Happy Holidays from Sussex Research!
Society for Glycobiology (SfG) Annual Meeting 2025
21st Annual Meeting of the Oligonucleotide Therapeutics Society (OTS)
26th Annual RiboClub 2025
4th Annual Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit
BIO International Convention 2025
CSC - Canadian Society of Chemistry
Gordon Research Conferences - Carbohydrates
CGS - Canadian Glycomics Symposium & Glyco27
TIDES - Oligo & Peptide Therapeutics
SDGS - San Diego Glycobiology Symposium
ACS CARB: Celebrating a Legacy of Glycoscience: A Symposium Honoring Chi-Huey Wong
Sussex Research Exhibits at Oligonucleotide Therapeutics Society (OTS2024) in Montreal
Sussex Research Sponsors 7th Canadian Glycomics Symposium (#CGS2024) & the 10th Warren Workshop chaired by GlycoNet
Sussex Research Participates in TIDES 2024 - Oligonucleotides & Peptide Therapeutics
Sussex Research Attends Helping With Furniture Charity Gala
Sussex Research Laboratories Inc. Official Sponsor of San Diego Glycobiology Symposium (SDGS) 2024
Sussex Research Laboratories Inc. to Exhibit at the 9th Annual OPT Congress
Sussex Research Laboratories Inc. to Exhibit at Society for Glycobiology's annual meeting Hawaii
Sussex Research Laboratories Inc. to Exhibit at BPS 2023 in Napa, California
Sussex Research Laboratories Inc. to Exhibit at Glyco26 in Taipei, Taiwan
Sussex Research Laboratories Inc. Welcomes Dr. Nycholat as New CSO and Director of U.S. Subsidiary in San Diego
Sussex Research Laboratories Inc. Official Sponsor of Glyconet's Canadian Glycomics Symposium 2023
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2023: Oligonucleotide & Peptide Therapeutics
Sussex Research Laboratories Inc. to Attend the Landmark Glycobiology Symposium (LGS)
Sussex Research Laboratories Inc. to Attend the 25th Annual San Diego Glycobiology Symposium (SDGS)
Sussex Research Laboratories Inc. to Exhibit at the 8th Annual OPT Congress
Sussex Research Laboratories Inc. Appoints Dr. Corwin Nycholat to Advisory Board
Sussex Research Laboratories Inc. to Exhibit at TIDES USA 2022: Oligonucleotide & Peptide Therapeutics
Sussex Research Laboratories Inc. to Exhibit at The American Peptide Symposium 2022 - "Peptide Science at the Summit"
Sussex Research Laboratories Inc. / Queen’s University collaboration receives support to develop novel small molecule therapies for COVID-19
Sussex Research Laboratories Inc. / Queen’s University collaboration receives Collaborative Research and Development Grant (CRDPJ) to develop synthetic strategies toward Deuterium-labeled pharmaceutical compounds with improved efficacy
Sussex Research Laboratories In. presents data on “Post Translationally Modified Cosmeceutical Actives” at the International Federation of Societies for Cosmetic Chemists (IFSCC) Congress in Paris
Sussex Research Laboratories Inc. acquires Chemaphor Chemical Services from Avivagen
Sussex Research Laboratories Inc. receives Notice of Allowance for Glycopeptide Cosmetic Active technology patent
Sussex Research Laboratories Inc. announces successful Clinical Trial Results for Glycolastin its Novel Anti-Aging Glycopeptide Cosmetic Active